Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 27 | 21 | −6 |
| Shares | 9.96M | 9.31M | −647.1K (−6.5%) |
| Value | $2.90M | $1.66M | −$1.24M (−42.8%) |
New holders (2)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 15,835 | $2.82K | 0.00% |
| JPMorgan Chase & Co | 21 | $4 | 0.00% |
Sold out (8)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Linden Advisors LP | 454,916 | $132.4K |
| HRT Financial LP | 49,165 | $14.0K |
| Virtu Financial LLC | 28,362 | $8.00K |
| Charles Schwab Investment Management Inc | 22,638 | $6.59K |
| Millennium Management LLC | 21,169 | $6.16K |
| We Are One Seven, LLC | 11,780 | $3.43K |
| ICA Group Wealth Management, LLC | 100 | $29 |
| FMR LLC | 14 | $4 |